Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

METAMIZOLE IMPURITY A CRS (15MG)

METAMIZOLE IMPURITY A CRS (15MG)

1672-58-8

DISCOVER
METFORMIN HYDROCHLORIDE CRS (50 MG)

METFORMIN HYDROCHLORIDE CRS (50 MG)

1115-70-4

DISCOVER
METHACRYLIC ACID-ETHYL ACRYLATE COPOLYMER (1:1) DISPERSION 3

METHACRYLIC ACID-ETHYL ACRYLATE COPOLYMER (1:1) DISPERSION 3

NA

DISCOVER
Monensin sodium salt

Monensin sodium salt

22373-78-0

DISCOVER
Methylbufotenin

Methylbufotenin

1019-45-0

DISCOVER
Morphine - STUP

Morphine - STUP

57-27-2

DISCOVER
METHADONE HYDROCHLORIDE - REFERENCE SPECTRUM (N/A)

METHADONE HYDROCHLORIDE - REFERENCE SPECTRUM (N/A)

NA

DISCOVER
DL-METHIONINE CRS (50 MG)

DL-METHIONINE CRS (50 MG)

59-51-8

DISCOVER
METHIONINE CRS (60 MG)

METHIONINE CRS (60 MG)

63-68-3

DISCOVER
METHOTREXATE CRS (100 MG)

METHOTREXATE CRS (100 MG)

59-05-2

DISCOVER
METHOTREXATE IMPURITY D CRS (15 MG)

METHOTREXATE IMPURITY D CRS (15 MG)

NA

DISCOVER
Metronidazole

Metronidazole

443-48-1

DISCOVER